期刊基本信息
- ISSN: 2213-2600
- 是否OA: 否
- 发刊频率: 月刊
- 创刊时间: 2000
- 出版语言: English
- 出版地区: Elsevier Ltd
- 出版商: ENGLAND
《柳叶刀》呼吸医学提供全面、clinically-focused覆盖所有地区的呼吸道药物和急救护理,包括但不限于:慢性阻塞性肺病、哮喘、囊性纤维化、IPF、肺炎、流感、肺结核、结节病、肺高血压、睡眠医学、呼吸道感染、肺血管疾病,肺癌,烟草控制,胸和重建手术,间皮瘤,姑息医学。继续在《柳叶刀》杂志上出版的传统影响力的内容,影响医疗实践,每一个月期的《柳叶刀》杂志上呼吸医学包含原始研究,评论,个人观点,评论,和新闻。《柳叶刀》杂志上呼吸医学是严格的编辑和同行评议,确保科学价值和临床意义的不同内容。原始研究顺利出版在8周内提交(平均)和网上发布的第一次出现在打印前在www.thelancet.com上。现在在PubMed索引,期刊引证报告®,斯高帕斯,《华尔街日报》接受提交的原始研究,评论,个人观点,和评论。访问http://ees.elsevier.com/thelancetrm以了解更多关于我们的编辑范围和目标和提交你的手稿。黄金或绿色开放获取可供选择支持的研究资助机构与爱思唯尔有一个协议。《华尔街日报》也在中低国家免费提供给读者通过HINARI计划
The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI program
发表评论